- Home
- FEAM vs ICU Comparison
FEAM vs ICU Comparison
Compare FEAM & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FEAM
- ICU
- Stock Information
- Founded
- FEAM 2016
- ICU 2018
- Country
- FEAM United States
- ICU United States
- Employees
- FEAM N/A
- ICU N/A
- Industry
- FEAM Major Chemicals
- ICU Biotechnology: Pharmaceutical Preparations
- Sector
- FEAM Industrials
- ICU Health Care
- Exchange
- FEAM Nasdaq
- ICU Nasdaq
- Market Cap
- FEAM 12.8M
- ICU 10.4M
- IPO Year
- FEAM N/A
- ICU N/A
- Fundamental
- Price
- FEAM $3.51
- ICU $0.42
- Analyst Decision
- FEAM Strong Buy
- ICU
- Analyst Count
- FEAM 2
- ICU 0
- Target Price
- FEAM $121.00
- ICU N/A
- AVG Volume (30 Days)
- FEAM 11.9K
- ICU 15.9M
- Earning Date
- FEAM 05-15-2025
- ICU 08-12-2025
- Dividend Yield
- FEAM N/A
- ICU N/A
- EPS Growth
- FEAM N/A
- ICU N/A
- EPS
- FEAM N/A
- ICU N/A
- Revenue
- FEAM N/A
- ICU $428,000.00
- Revenue This Year
- FEAM N/A
- ICU $754.07
- Revenue Next Year
- FEAM N/A
- ICU $100.09
- P/E Ratio
- FEAM N/A
- ICU N/A
- Revenue Growth
- FEAM N/A
- ICU N/A
- 52 Week Low
- FEAM $2.82
- ICU $0.31
- 52 Week High
- FEAM $33.81
- ICU $13.85
- Technical
- Relative Strength Index (RSI)
- FEAM 33.46
- ICU 18.81
- Support Level
- FEAM $3.41
- ICU $0.31
- Resistance Level
- FEAM $3.85
- ICU $0.67
- Average True Range (ATR)
- FEAM 0.28
- ICU 0.12
- MACD
- FEAM -0.06
- ICU -0.08
- Stochastic Oscillator
- FEAM 15.24
- ICU 11.55
About FEAM 5E Advanced Materials Inc.
5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.